4MN-21575-84411 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-19
Dose 1 — Pfizer-BioNTech
2021-04-13
Registered in v-safe
2021-04-13
Dose 2 — Pfizer-BioNTech
2021-04-13
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-20
Health check-in — day 7, dose 2
Feeling: Fair · Headache · Be unable to do your normal daily activities

Adult check-in
2021-04-27
Survey response — day 14, dose 2
MedDRA: Emergency care, Epistaxis — Feeling: Fair · Be unable to do your normal daily activities

Free text: Had a significant nosebleed that lasted 2 hours. A day later had a significant nosebleed that lasted 8 hours. Did not seek medical care due to time of occurrence left ER only option

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-04
Survey response — day 21, dose 2
MedDRA: Emergency care, Epistaxis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Nose bleeds continued to get worse. Went to urgent care after multiple prolonged nosebleeds. Using 12 sticks of silver nitrate they still could not carterize and stop the bleeding. Was sent to ER. ER couldnt stop it so scheduled for ENT.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-04
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-11
Survey response — day 28, dose 2
MedDRA: Epistaxis — Feeling: Fair · Be unable to do your normal daily activities

Free text: Continuation of unexplained nosebleeds

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2022-01-04
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-19	Pfizer-BioNTech
2	2021-04-13	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 8 — day 14, dose 2

2021-04-27

Symptoms: Had a significant nosebleed that lasted 2 hours. A day later had a significant nosebleed that lasted 8 hours. Did not seek medical care due to time of occurrence left ER only option

Release 8 — day 21, dose 2

2021-05-04

Symptoms: Nose bleeds continued to get worse. Went to urgent care after multiple prolonged nosebleeds. Using 12 sticks of silver nitrate they still could not carterize and stop the bleeding. Was sent to ER. ER couldnt stop it so scheduled for ENT.

Release 8 — day 28, dose 2

2021-05-11

Symptoms: Continuation of unexplained nosebleeds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Emergency care	✓	✓	✓
SD	Epistaxis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release